PPP2R5E expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 4.0921999122645E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.94459999991459E-07 |
Normal-vs-Stage2 |
2.37579999999848E-05 |
Normal-vs-Stage3 |
3.1119995469453E-11 |
Normal-vs-Stage4 |
4.04790000407829E-08 |
Stage1-vs-Stage2 |
3.392600E-01 |
Stage1-vs-Stage3 |
9.172100E-04 |
Stage1-vs-Stage4 |
2.527500E-02 |
Stage2-vs-Stage3 |
2.633800E-01 |
Stage2-vs-Stage4 |
4.371600E-01 |
Stage3-vs-Stage4 |
8.286400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
5.75790004564425E-09 |
Normal-vs-AfricanAmerican |
1.01640029726013E-10 |
Normal-vs-Asian |
7.153700E-02 |
Caucasian-vs-AfricanAmerican |
8.337600E-03 |
Caucasian-vs-Asian |
7.094400E-01 |
AfricanAmerican-vs-Asian |
1.379210E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.46469955555995E-10 |
Normal-vs-Female |
1.77510000032299E-07 |
Male-vs-Female |
1.830400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.85489999999988E-05 |
Normal-vs-Age(41-60Yrs) |
3.7862000001887E-07 |
Normal-vs-Age(61-80Yrs) |
5.24047472083566E-12 |
Normal-vs-Age(81-100Yrs) |
2.07109999994515E-06 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.622400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.914000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.493400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.402300E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.239050E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.842600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.036020E-01 |
Normal-vs-Grade 2 |
2.45759999999429E-05 |
Normal-vs-Grade 3 |
1.68720593052285E-12 |
Normal-vs-Grade 4 |
6.43870001759694E-09 |
Grade 1-vs-Grade 2 |
5.468800E-01 |
Grade 1-vs-Grade 3 |
3.240100E-02 |
Grade 1-vs-Grade 4 |
6.012300E-02 |
Grade 2-vs-Grade 3 |
6.245700E-04 |
Grade 2-vs-Grade 4 |
4.221100E-03 |
Grade 3-vs-Grade 4 |
4.865000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
2.26509999999847E-05 |
Normal-vs-ccB subtype |
2.62320000166127E-08 |
ccA subtype-vs-ccB subtype |
4.396300E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.29680000018995E-07 |
Normal-vs-N1 |
4.15789999996807E-06 |
N0-vs-N1 |
8.196400E-02 |
|
|